Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien looks to China for R&D expertise; Medtronic continues eastern expansion

This article was originally published in Clinica

Executive Summary

Covidien is establishing a flagship R&D centre in Shanghai, China, which will become the company's nerve centre for new product development focused on the specific needs of patients in China and other emerging market countries. The 10,000-square foot facility, which will be based in Shanghai Caohejing Hi-Tech Park, is expected to be fully operational by July 2012. Its creation will also significantly boost the number of Covidien's employees in the country; currently the firm has a 25-strong R&D team in Shanghai and this is expected to increase to over 300 when the facility is completed. Covidien will be drawing on this enlarged pool of expertise in Asia to create and develop new medical device technologies for markets worldwide.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel